Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.430
-0.060 (-1.72%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Rocket Pharmaceuticals Employees
Rocket Pharmaceuticals had 202 employees as of December 31, 2025. The number of employees decreased by 97 or -32.44% compared to the previous year.
Employees
202
Change (1Y)
-97
Growth (1Y)
-32.44%
Revenue / Employee
n/a
Profits / Employee
-$1,104,569
Market Cap
374.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Silence Therapeutics | 88 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 53 |
| X4 Pharmaceuticals | 45 |
| Avalo Therapeutics | 33 |
RCKT News
- 21 hours ago - Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher - Business Wire
- 4 weeks ago - Rocket Pharmaceuticals Transcript: FDA announcement - Transcripts
- 4 weeks ago - Rocket Pharma shares climb as FDA approves first therapy for deadly childhood disorder - Reuters
- 4 weeks ago - Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) - Business Wire
- 7 weeks ago - Rocket Pharmaceuticals Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Rocket Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress - Business Wire
- 2 months ago - Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire